Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025)
Benitec Biopharma's Enterprise Value history spans 7 years, with the latest figure at -$103.6 million for Q1 2025.
- For Q1 2025, Enterprise Value changed N/A year-over-year to -$103.6 million; the TTM value through Mar 2025 reached -$103.6 million, changed N/A, while the annual FY2024 figure was -$50.9 million, 1945.34% down from the prior year.
- Enterprise Value for Q1 2025 was -$103.6 million at Benitec Biopharma, down from -$78.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.5 million in Q2 2023 and bottomed at -$103.6 million in Q1 2025.
- The 5-year median for Enterprise Value is -$16.1 million (2021), against an average of -$28.5 million.
- The largest annual shift saw Enterprise Value skyrocketed 79.4% in 2022 before it tumbled 1945.34% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$12.3 million in 2021, then rose by 14.52% to -$10.5 million in 2022, then crashed by 93.91% to -$20.4 million in 2023, then crashed by 284.27% to -$78.3 million in 2024, then tumbled by 32.29% to -$103.6 million in 2025.
- Per Business Quant, the three most recent readings for BNTC's Enterprise Value are -$103.6 million (Q1 2025), -$78.3 million (Q4 2024), and -$67.9 million (Q3 2024).